美國居民不適用 XM 服務。

B
B

Biogen

交易方向

交易者脈動

技術摘要

小時

財經新聞

Reuters - 15小時前

U.S. STOCKS Franchise Group, Connect Biopharma, OSI Systems

BUZZ-U.S. STOCKS ON THE MOVE-Franchise Group, Connect Biopharma, OSI Systems Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the Dow Jones gained on Monday as a state-backed rescue of embattled lender Credit Suisse helped calm some jitters around a bigger banking crisis, while investors weighed odds of the Federal Reserve pausing its rate hikes this week.
A
B
B
C
C
C
G
G
I
J
M
N
P
T
U
A
F
R
U
U
F
W
C
F
L
R
U
Reuters - 18小時前

FDA staff says safety issues with Biogen's ALS drug to not prevent approval

UPDATE 2-FDA staff says safety issues with Biogen's ALS drug to not prevent approval Adds trial details By Bhanvi Satija March 20 (Reuters) - The U.S. health regulator's staff said on Monday safety issues with Biogen Inc's BIIB.O drug to treat an ultra-rare form of amyotrophic lateral sclerosis or ALS, also known as Lou Gehrig's disease, should not prevent its accelerated approval.
B
Reuters - 18小時前

US FDA staff flags no new safety concerns for Biogen's ALS drug

US FDA staff flags no new safety concerns for Biogen's ALS drug March 20 (Reuters) - The U.S. Food and Drug Administration's staff reviewers on Monday did not raise any new safety concerns about Biogen Inc's BIIB.O experimental drug for treating a rare type of amyotrophic lateral sclerosis, also known as Lou Gehrig's disease. Reporting by Raghav Ma
B
Reuters - 19小時前

U.S. STOCKS WestRock, PacWest, Foot Locker

BUZZ-U.S. STOCKS ON THE MOVE-WestRock, PacWest, Foot Locker Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes were set for a subdued open in volatile trading on Monday as investors weighed a state-backed takeover of Credit Suisse and the odds of the Federal Reserve keeping interest rates unchanged this week.
A
B
B
C
C
C
G
G
J
M
N
P
T
U
U
W
C
F
R
Reuters - 5天前

Biogen Receives Favorable Decision From European Union's Court Of Justice On TECFIDERA Regulatory Data

BRIEF-Biogen Receives Favorable Decision From European Union's Court Of Justice On TECFIDERA Regulatory Data March 16 (Reuters) - Biogen Inc BIIB.O : BIOGEN RECEIVES FAVORABLE DECISION FROM COURT OF JUSTICE OF THE EUROPEAN UNION RELATING TO TECFIDERA® (DIMETHYL FUMARATE) REGULATORY DATA AND MARKETING PROTECTION BIOGEN - BELIEVES TECFIDERA IS ENTIT
B

細節

熱門資產

免責聲明: XM Group提供線上交易平台的登入和執行服務，允許個人查看和/或使用網站所提供的內容，但不進行任何更改或擴展其服務和訪問權限，並受以下條款與條例約束：（i）條款與條例；（ii）風險提示；（iii）完全免責聲明。網站內部所提供的所有資訊，僅限於一般資訊用途。請注意，我們所有的線上交易平台內容並不構成，也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料，僅適用於教育/資訊類用途，不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議，或是交易價格紀錄，或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容，包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接，皆爲‘按原狀’，並作爲一般市場評論所提供，而非投資建議。請理解和接受，所有被歸類為投資研究範圍的相關内容，並非爲了促進投資研究獨立性，而根據法律要求所編寫，而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊，相關詳情請點擊 這裡查看。

我們運用 cookies 提供您最佳之網頁使用經驗。更改您的cookie 設定跟詳情。

風險提示：您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明。